Annual Drug Patent Expirations for ROZEREM
Rozerem is a drug marketed by Takeda Pharms Usa and is included in one NDA. It is available from one supplier. There is one patent protecting this drug and one Paragraph IV challenge.
This drug has twelve patent family members in seven countries.
The generic ingredient in ROZEREM is ramelteon. One supplier is listed for this compound. Additional details are available on the ramelteon profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
